AIM ImmunoTech Inc. (AIM) Form 424B3 — Jun 18, 2026
AIM ImmunoTech Inc. filed a prospectus supplement for the resale of up to 31,287,933 shares of common stock by selling stockholders. These shares are issuable upon the exercise of Class H and Class I warrants issued in May 2026 financing transactions, as well as placement agent warrants. The potential dilution represents approximately 128.6% of the company’s outstanding shares as of May 29, 2026.
Key figures
- Gross Proceeds
- 14.5
- Shares Offered
- 31,287,933
- Shares Outstanding
- 24,328,623
- Last Sale Price
- $0.40
- Dilution Percentage
- 128.6
- Stockholders Equity
- $6.5 million
- Warrant Exercise Price Class H
- $0.60
- Warrant Exercise Price Class I
- $0.325
- Warrant Exercise Price Placement Agent
- $0.40625
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.